PubMed

Suboptimal monitoring and dosing of unfractionated heparin in comparative studies with low-molecular-weight heparin.

Raschke R, Hirsh J, Guidry JR.

Ann Intern Med. 2003 May 6;138(9):720-3.PMID: 12729426 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators.

JAMA. 2006 Aug 23;296(8):935-42.PMID: 16926353 [PubMed - indexed for MEDLINE]Related articlesFree article

Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.

Hull RD, Pineo GF, Stein P.

Int Angiol. 1998 Dec;17(4):213-24. Review.PMID: 10204652 [PubMed - indexed for MEDLINE]Related articles

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Quinlan DJ, McQuillan A, Eikelboom JW.

Ann Intern Med. 2004 Feb 3;140(3):175-83.PMID: 14757615 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. What is the most effective blood thinner for treating patients with blood clots in the veins?

[No authors listed]

Ann Intern Med. 2003 May 6;138(9):I63. No abstract available. PMID: 12729447 [PubMed - indexed for MEDLINE]Related articlesFree article

Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.

Kearon C.

Curr Opin Pulm Med. 2007 Sep;13(5):398-402. Review.PMID: 17940484 [PubMed - indexed for MEDLINE]Related articles

Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism.

Bernardi E, Prandoni P.

Curr Opin Pulm Med. 2005 Sep;11(5):363-7. Review.PMID: 16093806 [PubMed - indexed for MEDLINE]Related articles

Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?

Hull RD, Pineo GF.

Semin Thromb Hemost. 2004 Feb;30 Suppl 1:11-23. Review.PMID: 15085462 [PubMed - indexed for MEDLINE]Related articles

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.

Ann Intern Med. 1999 May 18;130(10):800-9.PMID: 10366369 [PubMed - indexed for MEDLINE]Related articlesFree article

Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.

Pineo GF, Hull RD.

Baillieres Clin Haematol. 1998 Sep;11(3):621-37. Review.PMID: 10331096 [PubMed - indexed for MEDLINE]Related articles

A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.

Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M.

Arch Intern Med. 1994 Jan 10;154(1):49-56.PMID: 8267489 [PubMed - indexed for MEDLINE]Related articles

Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring.

Taylor CT, Petros WP, Ortel TL.

Pharmacotherapy. 1999 Apr;19(4):383-7.PMID: 10212007 [PubMed - indexed for MEDLINE]Related articles

Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.

Kearon C, Harrison L, Crowther M, Ginsberg JS.

Thromb Res. 2000 Mar 15;97(6):395-403.PMID: 10704648 [PubMed - indexed for MEDLINE]Related articles

Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.

Anand SS, Bates S, Ginsberg JS, Levine M, Buller H, Prins M, Haley S, Kearon C, Hirsh J, Gent M.

Arch Intern Med. 1999 Sep 27;159(17):2029-32.PMID: 10510988 [PubMed - indexed for MEDLINE]Related articlesFree article

Monitoring unfractionated heparin with the aPTT: time for a fresh look.

Eikelboom JW, Hirsh J.

Thromb Haemost. 2006 Nov;96(5):547-52. Review.PMID: 17080209 [PubMed - indexed for MEDLINE]Related articles

Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.

Prandoni P, Carnovali M, Marchiori A; Galilei Investigators.

Arch Intern Med. 2004 May 24;164(10):1077-83.PMID: 15159264 [PubMed - indexed for MEDLINE]Related articlesFree article

Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.

Couturaud F, Julian JA, Kearon C.

Thromb Haemost. 2001 Oct;86(4):980-4.PMID: 11686355 [PubMed - indexed for MEDLINE]Related articles

Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.

Spinler SA, Wittkowsky AK, Nutescu EA, Smythe MA.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1275-85. Epub 2005 Jun 14. Review.PMID: 15956240 [PubMed - indexed for MEDLINE]Related articles

The use of the activated clotting time for monitoring heparin therapy in critically ill patients.

De Waele JJ, Van Cauwenberghe S, Hoste E, Benoit D, Colardyn F.

Intensive Care Med. 2003 Feb;29(2):325-8. Epub 2003 Jan 16. Erratum in: Intensive Care Med. 2003 Apr;29(4):664. PMID: 12594595 [PubMed - indexed for MEDLINE]Related articles

Low-molecular-weight heparin in the treatment of pulmonary embolism.

Ageno W, Turpie AG.

Semin Vasc Surg. 2000 Sep;13(3):189-93. Review.PMID: 11005462 [PubMed - indexed for MEDLINE]Related articles